Interxion Opens MRS2, Its Second Data Centre in Marseille
INTERXION HOLDING NV (NYSE: INXN), a leading European provider of carrier and cloud-neutral colocation data centre services, today announced that it has officially opened the first phase of MRS2, Interxion’s second data centre in Marseille.
Less than four years after acquiring its first data centre in Marseille, Interxion is continuing to expand its presence in the southern French city. Located at the Port of Marseille Fos, MRS2 will meet the growing demand from international connectivity and content providers, and cloud platforms wanting to use Marseille as a hub to deliver their services and applications to Europe and further afield to Africa, the Middle East and Asia.
MRS2 is being built in three phases, which will offer customers 4,400 sqm of equipable space with over 7MW of available power. The new phase, which is now completed, consists of 700 sqm of equipable space, while the second will offer 1,900 sqm from the second quarter of 2019. The capital expenditure associated with the construction of MRS2 as a whole is expected to be approximately €76 million.
Together with MRS1, the new data centre allows a campus configuration, giving customers diversity of routes to ensure the resilience of their networks, as well as capacity for further expansion.
MRS2 also means the refurbishment of some installations at Marseille Fos Port, which were historically linked to port activity. The data centre is based in former naval workshops, Freyssinet-style buildings, which have been unoccupied since the 1990s. Construction of MRS2 is managed by Cap Ingelec in a consortium with Cari, a subsidiary of Fayat Group.
Marseille has become the Mediterranean capital for telecom, cloud and digital exchanges. Its geographic position as the landing point for 13 submarine telecommunications cables is a significant advantage. These cables, including some that are more than 20,000 km long, connect Marseille to dozens of countries as far as Singapore and China. The city is therefore a crossroads of connectivity between southern Europe, Asia, Africa and the Middle East, and has become a strategic global hub for data exchange. This trend is still ongoing with the arrival of new submarine cables, increasing the available network capacity in Marseille.
“Opening MRS2 is an important second step for Interxion in developing Marseille as a digital hub,” said David Ruberg, Interxion CEO. “This investment in the heart of the Mediterranean will help us to respond to the growing demand of our customers who wish to expand to Marseille to develop their activity in Europe and to reach emerging markets in Africa, the Middle East and Asia.”
For Fabrice Coquio, Managing Director of Interxion France, “MRS2 is the continuation of what we started with MRS1 when Interxion acquired the facility in 2014. I am proud and honoured today to open this new data centre, which is particularly notable due to its position within the grounds of Marseille Fos Port, forming, together with MRS1, the Interxion’s Marseille Campus. The number of telecom providers in Marseille is growing with the arrival of cloud and digital media platforms, confirming Marseille not only as a connectivity hub, but also as a content hub.”
Jean-Claude Gaudin, President of the Aix-Marseille-Provence Metropolis, Mayor of Marseille, Honorary Vice-president of the French Senate said, “We are particularly proud to attend the inauguration of Interxion’s MRS2 data centre, an addition to the several assets the Aix-Marseille-Provence Metropolis has in the digital field. These vast centres of IT servers that store and process data for companies support the digital transformation of our territory. Located in the Port of Marseille Fos, this new site has a role to play in supporting the development of Marseille as a global hub for telecom, cloud and digital exchanges. It reflects the willingness of the Aix-Marseille-Provence Metropolis to place the digital sector at the very heart of its development and attractiveness strategy.”
Mounir Mahjoubi, French Minister of State for Digital Affairs, attached to the Prime Minister said, “The opening of this second Interxion data centre in Marseille is a prime example of the Aix-Marseille region’s attractiveness for companies investing in forward-looking sectors. This infrastructure will contribute to reinforcing Marseille as a growing digital hub, where new uses of the Internet represent a true opportunity for France. Our country has many assets that can be leveraged by the digital sector, has very fine startups and companies, and already attracts a number of foreign investments. I am pleased in the expansion of this industry in Marseille and the Bouches-du-Rhône department – it is a true driver of economic growth and long-term job creation.”
Interxion (NYSE: INXN) is a leading provider of carrier and cloud-neutral colocation data centre services in Europe, serving a wide range of customers through 50 data centres in 11 European countries. Interxion’s uniformly designed, energy efficient data centres offer customers extensive security and uptime for their mission-critical applications.
With over 700 connectivity providers, 21 European Internet exchanges, and most leading cloud and digital media platforms across its footprint, Interxion has created connectivity, cloud, content and finance hubs that foster growing customer communities of interest. For more information, please visit www.interxion.com.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Ultra-Low Power Lattice sensAI Leads Mass Market Enablement of Artificial Intelligence in Edge Devices21.5.2018 12:00 | Pressemelding
Lattice Semiconductor Corporation (NASDAQ: LSCC) today unveiled Lattice sensAI™ – a complete technology stack combining modular hardware kits, neural network IP cores, software tools, reference designs and custom design services – to accelerate integration of machine learning inferencing into broad market IoT applications. With solutions optimized for ultra-low power consumption (under 1 mW–1 W), small package size (5.5 mm2 –100 mm2), interface flexibility (MIPI® CSI-2, LVDS, GigE, etc.), and high-volume pricing (~$1-$10 USD), Lattice sensAI stack fast-tracks implementation of edge computing close to the source of data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005011/en/ (Graphic: Business Wire) “Lattice sensAI addresses the unmet need for flexible, low cost, ultra-low power AI silicon solutions suited for rapid deployment across a wide range of emerging, mass market IoT applications,” said Deepak Boppana, senior
NioCorp Awards Contract to Rockwell Automation on Groundbreaking Critical Minerals, Mining and Processing Facility in Nebraska21.5.2018 12:00 | Pressemelding
NioCorp Developments Ltd. (TSX: NB, OTCQX: NIOBF), a developer of superalloy metals, has awarded a major contract to Rockwell Automation (NYSE: ROK) to engineer, design and procure process automation and instrumentation for NioCorp’s proposed critical minerals, mining and processing facility in Elk Creek, Nebraska. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005228/en/ Three superalloy metals – niobium, scandium and titanium – are expected to be produced by the facility as early as 2021. These critical materials are used in the aerospace, defense, automotive, clean energy, commercial aviation and mega-infrastructure sectors. Generally, these superalloys enable increased strength and lighter weight in transportation and other systems, leading to better fuel efficiency and lower greenhouse gas and other air emissions, according to NioCorp. “We selected Rockwell Automation and its partners to automate our process equip
Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare21.5.2018 11:27 | Pressemelding
At the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 23rd Annual International Meeting in Baltimore, Celltrion Healthcare today advocated for healthcare systems to introduce biologics earlier in a patient’s treatment regimen in order to improve clinical outcomes. Several studies show that the early introduction of biologics can bring greater clinical benefit to patients.1,2,3,4,5,6 However, only a limited number of patients have access to biological treatment due to the high-cost of biologics and current reimbursement policies determined by pharmacoeconomic evaluations. Since the introduction of biosimilars, the overall cost of biological treatments has reduced in Europe, allowing an increased number of patients to access this important treatment option earlier in their course of treatment.7 Professor Jørgen Jahnsen said, “For the treatment of inflammatory bowel disease, biological treatments are proven to be the most efficacious medical therapy and their ea
Dole’s Joint Venture Recycling Company Celebrates 25 Years21.5.2018 11:00 | Pressemelding
Dole Food Company announced today that Recyplast S.A., an innovative plastic recycling company based in Costa Rica and with joint ownership including a subsidiary of Dole Fresh Fruit, recently surpassed 25 years in its mission to dramatically reduce and reuse agricultural waste. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180521005160/en/ Raul Martinez (right), General Manager of Dole Standard Fruit de Costa Rica, receives a plaque from Jose Miguel Ramirez, General Manager of Recyplast, in recognition of the contribution of Dole's banana plantations in the correct handling, storage, and provision of field plastic waste. The plastic recycling facility pioneered the collection of field plastics after use in banana growing operations in Costa Rica. This reuse and recycling process includes reclamation of plastic bags that protect bananas from weather and insects, as well as the collection of plastic twine used to prop the ba
ViiV Healthcare Receives EU Marketing Authorisation for Juluca (dolutegravir/rilpivirine), the First 2-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV21.5.2018 10:11 | Pressemelding
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the European Commission has granted marketing authorisation for Juluca (dolutegravir 50mg/rilpivirine 25mg) for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor or integrase inhibitor.1 Juluca is a 2-drug regimen of dolutegravir (ViiV Healthcare), the most widely prescribed integrase inhibitor worldwide,2 and rilpivirine (Janssen Sciences Ireland UC, part of the Janssen Pharmaceutical Companies of Johnson & Johnson).1 Deborah Waterhouse, CEO ViiV Healthcare said, “The European Commission Decision for Juluca is very positive news for people living with
Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-121.5.2018 10:06 | Pressemelding
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has granted marketing authorisation for JULUCA® (dolutegravir 50mg [ViiV Healthcare]/rilpivirine 25mg [Janssen Sciences Ireland UC]).1 ViiV Healthcare, as the marketing authorisation holder, will market dolutegravir/rilpivirine in all countries in the European Union and European Economic Area. Dolutegravir/rilpivirine is the first two-drug regimen, once-daily, single-pill for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase inhibitor (INI).1 “The European Commission Decision for dolutegravir/rilpivirine marks a significant milestone in our 25-year commitment to make HIV history,” said Brian Woo